Imagine you’re a cancer researcher. In the lab, you’re up to your elbows testing how cancer cell lines react to different drug combinations – hoping that all your long hours and hard work in the Petri dish will result in a successful treatment you can deliver to the grandparent, soccer mom, coach or even 9-year-old little league player you see in the clinic.
What if along your road to oncology alchemy, you uncover a novel approach to treat your patient’s cancer with another compound that’s shown success in other diseases. It should be simple enough to get access to this compound and begin testing, right?
In actuality, the process of drug co-development is a lot more complex than that. Breast cancer researcher and clinical investigator Dr. Bhuvaneswari Ramaswamy, of The Ohio State University Comprehensive Cancer Center, breaks down how this process affects her and her patients in the video below.






